Rocket Pharmaceuticals, Inc. (RCKT)
3.01
+0.01
(+0.33%)
USD |
NASDAQ |
May 27, 15:01
Rocket Pharmaceuticals Cash from Investing (Quarterly) : 17.45M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AnaptysBio, Inc. | 34.98M |
| Arcus Biosciences, Inc. | 114.00M |
| Replimune Group, Inc. | 75.12M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -45.39M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -179.81M |
| Free Cash Flow Per Share (Quarterly) | -0.4056 |
| Free Cash Flow to Equity (Quarterly) | -45.37M |
| Free Cash Flow to Firm (Quarterly) | -45.01M |
| Free Cash Flow Yield | -53.51% |